SAN

83.29

-0.37%↓

MRK1

110.9

-0.36%↓

SHL.DE

46.1

-0.88%↓

ARGX

490.5

-0.06%↓

FRE

40.89

-0.58%↓

SAN

83.29

-0.37%↓

MRK1

110.9

-0.36%↓

SHL.DE

46.1

-0.88%↓

ARGX

490.5

-0.06%↓

FRE

40.89

-0.58%↓

SAN

83.29

-0.37%↓

MRK1

110.9

-0.36%↓

SHL.DE

46.1

-0.88%↓

ARGX

490.5

-0.06%↓

FRE

40.89

-0.58%↓

SAN

83.29

-0.37%↓

MRK1

110.9

-0.36%↓

SHL.DE

46.1

-0.88%↓

ARGX

490.5

-0.06%↓

FRE

40.89

-0.58%↓

SAN

83.29

-0.37%↓

MRK1

110.9

-0.36%↓

SHL.DE

46.1

-0.88%↓

ARGX

490.5

-0.06%↓

FRE

40.89

-0.58%↓

Search

Orion Oyj (Class B)

Slēgts

69.45 5.07

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

65.45

Max

69.65

Galvenie mērījumi

By Trading Economics

Ienākumi

-12M

61M

Pārdošana

-80M

355M

P/E

Sektora vidējais

26.714

39.857

EPS

0.44

Dividenžu ienesīgums

2.57

Peļņas marža

17.287

Darbinieki

3,943

EBITDA

202M

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

2.57%

2.42%

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

3.4B

8.9B

Iepriekšējā atvēršanas cena

64.38

Iepriekšējā slēgšanas cena

69.45

Orion Oyj (Class B) Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 17. jūl. 23:34 UTC

Iegādes, apvienošanās, pārņemšana

FTC Reopens Consent Orders for Proposed Acquisitions from Exxon Mobil, Chevron

2025. g. 17. jūl. 21:14 UTC

Iegādes, apvienošanās, pārņemšana

Basel Medical Group Puts $1 Billion Bitcoin Purchase on Hold

2025. g. 17. jūl. 21:04 UTC

Galvenie tirgus virzītāji
Iegādes, apvienošanās, pārņemšana

Norfolk Southern Shares Rise on WSJ Report of Union Pacific Acquisition Interest

2025. g. 17. jūl. 23:43 UTC

Tirgus saruna

Gold Edges Higher on Possible Position Adjustments -- Market Talk

2025. g. 17. jūl. 23:42 UTC

Tirgus saruna

Nikkei May Rise on Signs of U.S. Econ Strength -- Market Talk

2025. g. 17. jūl. 22:47 UTC

Iegādes, apvienošanās, pārņemšana

FTC: Maintaining Restrictions for Former Pioneer CEO Scott Sheffield Would Damage FTC's Credibility

2025. g. 17. jūl. 22:46 UTC

Iegādes, apvienošanās, pārņemšana

Potential Rail Merger Could Prompt Berkshire Hathaway to Bid for CSX -- Barrons.com

2025. g. 17. jūl. 22:46 UTC

Iegādes, apvienošanās, pārņemšana

FTC Also Says Exxon Order Disregarded Guidelines and Precedent

2025. g. 17. jūl. 22:43 UTC

Iegādes, apvienošanās, pārņemšana

FTC: Maintaining Restrictions on John Hess's Employment Would 'Damage the FTC's Credibility'

2025. g. 17. jūl. 22:43 UTC

Iegādes, apvienošanās, pārņemšana

FTC: Chevron Order Disregarded FTC Merger Guidelines and Decades of Precedent

2025. g. 17. jūl. 22:40 UTC

Iegādes, apvienošanās, pārņemšana

FTC Reopens and Sets Aside Chevron-Hess and Exxon-Pioneer Final Consent Orders

2025. g. 17. jūl. 22:40 UTC

Iegādes, apvienošanās, pārņemšana

FTC Reopens and Sets Aside Chevron-Hess and Exxon-Pioneer Final Consent Orders

2025. g. 17. jūl. 22:30 UTC

Tirgus saruna
Peļņas

Netflix Sticks to Its Playbook as Competitive Landscape Changes -- Market Talk

2025. g. 17. jūl. 22:20 UTC

Tirgus saruna
Peļņas

Global Equities Roundup: Market Talk

2025. g. 17. jūl. 22:20 UTC

Tirgus saruna
Peļņas

Netflix Focusing Resources on TV Viewers It Hasn't Yet Captured -- Market Talk

2025. g. 17. jūl. 22:04 UTC

Tirgus saruna
Peļņas

Netflix Redesign Done to Match Current Capabilities -- Market Talk

2025. g. 17. jūl. 22:03 UTC

Iegādes, apvienošanās, pārņemšana

China Threatens to Block Panama Ports Deal Unless Its Shipping Giant Is Part of It -- 2nd Update

2025. g. 17. jūl. 21:58 UTC

Tirgus saruna
Peļņas

Netflix Internal Data Doesn't Indicate Weaker Consumer Sentiment -- Market Talk

2025. g. 17. jūl. 21:57 UTC

Peļņas

Netflix Earnings Soar Past Expectations. How a Weak Dollar Helped Boost Results. -- Barrons.com

2025. g. 17. jūl. 21:47 UTC

Peļņas

Netflix Raises Revenue, Margin Forecasts After Strong Second Quarter -- Update

2025. g. 17. jūl. 21:45 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 17. jūl. 21:45 UTC

Tirgus saruna

Crypto Bills Welcomed by Venture Capital, Trade Group Says -- Market Talk

2025. g. 17. jūl. 21:38 UTC

Iegādes, apvienošanās, pārņemšana

Railroad Operator Union Pacific Exploring Deal for Norfolk Southern -- 2nd Update

2025. g. 17. jūl. 21:22 UTC

Iegādes, apvienošanās, pārņemšana

Update: Union Pacific Considering a Norfolk Southern Buyout: Report. -- Barrons.com

2025. g. 17. jūl. 21:05 UTC

Peļņas

Netflix Earnings Soar Past Expectations. How a Weak Dollar Helped Boost Results. -- Barrons.com

2025. g. 17. jūl. 21:04 UTC

Iegādes, apvienošanās, pārņemšana

Railroad Operator Union Pacific Exploring Deal for Norfolk Southern -- Update

2025. g. 17. jūl. 21:02 UTC

Iegādes, apvienošanās, pārņemšana

Union Pacific Considering a Norfolk Southern Buyout: Report. -- Barrons.com

2025. g. 17. jūl. 20:59 UTC

Iegādes, apvienošanās, pārņemšana

Basel Medical Group Puts $1B Bitcoin Purchase on Hold

2025. g. 17. jūl. 20:50 UTC

Tirgus saruna
Peļņas

Tech, Media & Telecom Roundup: Market Talk

2025. g. 17. jūl. 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

Salīdzinājums

Cenas izmaiņa

Orion Oyj (Class B) Prognoze

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Orion Oyj (Class B)

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson's disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer. It also offers Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. In addition, the company provides veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; APIs for generic compounds and proprietary products, as well as contract manufacturing services; and markets and sells veterinary drugs manufactured by other international companies. It has partnership with Propeller Health to connect the Easyhaler(R) product portfolio; collaboration and option to license agreement with Abilita Therapeutics to develop innovative antibody therapeutics; and a research collaboration and license agreement with Amneal Pharmaceuticals, Inc. to commercialize Amneal's generic products. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.